Contributions of the Norwegian Institute of Public Health to the development of vaccines against serogroup B meningococcal disease.
Rosenqvist
Einar
E
Holst
Johan
J
Nøkleby
Hanne
H
D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000627:therapeutic use*; D009520:New Zealand / Q000453:epidemiology; D009664:Norway / Q000453:epidemiology; D011634:Public Health; D018074:Vaccines, Conjugate / Q000382:microbiology / Q000627:therapeutic use*
D022401:Meningococcal Vaccines; D018074:Vaccines, Conjugate; C493331:meningococcal type B conjugate vaccine